Clinical Trials for the week of September 4

September 2, 2024 Clinical Trials
Clinical Trials, contributed by Howard A. Young
Clinical Trials, contributed by Howard A. Young

Pegylated Interferon Lambda for Treatment of COVID-19 Infection
ClinicalTrials.gov ID NCT04534673
Sponsor Soroka University Medical Center
Information provided by Ohad Etzion, Soroka University Medical Center (Responsible Party)
Last Update Posted 2023-05-06

Proportion of Clinical Improvement & Type 1 Interferon (IFN) Score Changes in Idiopathic Uveitis Patients With Interferon Gamma Release Assay (IGRA) Positive
ClinicalTrials.gov ID NCT04088019
Sponsor Fakultas Kedokteran Universitas Indonesia
Information provided by Rina, Fakultas Kedokteran Universitas Indonesia (Responsible Party)
Last Update Posted 2024-02-28

Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis (ATIOM)
ClinicalTrials.gov ID NCT05535764
Sponsor University of Utah
Information provided by University of Utah (Responsible Party)
Last Update Posted 2024-03-18

Related Articles

Clinical Trials, contributed by Howard A. Young
Clinical Trials

Clinical Trials for the week of August 21

August 19, 2024 Clinical Trials

Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma (ATPIC) | Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for Treatment of HIV | Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia [READ MORE]

Clinical Trials, contributed by Howard A. Young
Clinical Trials

Clinical Trials for the week of September 18

September 16, 2024 Clinical Trials

Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT | MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera (MITHRIDATE) | Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression (IPOS) [READ MORE]

Clinical Trials, contributed by Howard A. Young
Clinical Trials

Clinical Trials for the week of August 7

August 1, 2024 Clinical Trials

Clinical Trials of interest to cytokine & interferon researchers Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not? (BIOSTOP) ClinicalTrials.gov ID NCT03011268 Sponsor Helse Møre og Romsdal HF Information provided by Helse Møre og Romsdal HF (Responsible Party) Last Update Posted 2023-03-17 Evaluation of [READ MORE]